 |
 |

An Evaluation of Method Reporting and Use in Clinical Trials in Dermatology
Michael Bigby, MD;
Robert S. Stern, MD;
JudyAnn Bigby, MD
Arch Dermatol. 1985;121(11):1394-1399.
Abstract
In a survey of 62 clinical trials published in four dermatology journals, recommended methodology was reported 41% of the time. Of the 62 trials, 31 were open drug trials and 27 were controlled trials. Forty-one percent of 13 recommended methodologic items were reported in these articles. The rate of reporting for these items ranged from 3% for power and method of randomization to 76% for loss to follow-up and the use of a control group. There were no differences among journals in reporting methods used. Investigators and editors are encouraged to improve the reporting and use of recommended methodology in clinical trials published in the dermatologic literature.
(Arch Dermatol 1985;121:1394-1399)
Author Affiliations
From the Department of Dermatology and the Charles A. Dana Research Institute, Beth Israel Hospital and Harvard Medical School (Drs M. Bigby and Stern); and the Department of Medicine, Division of General Internal Medicine, Brigham and Women's Hospital and Harvard Medical School (Dr J. Bigby), Boston.
Footnotes
Accepted for publication May 24, 1985.
Reprint requests to Department of Dermatology, Beth Israel Hospital, Boston, MA 02215 (Dr M. Bigby).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?
Adetugbo and Williams
Arch Dermatol 2000;136:381-385.
ABSTRACT
| FULL TEXT
Evidence-Based Medicine in a Nutshell: A Guide to Finding and Using the Best Evidence in Caring for Patients
Bigby
Arch Dermatol 1998;134:1609-1618.
ABSTRACT
| FULL TEXT
The Cochrane Skin Group: Preparing, Maintaining, and Disseminating Systematic Reviews of Clinical Interventions in Dermatology
Williams et al.
Arch Dermatol 1998;134:1620-1626.
ABSTRACT
| FULL TEXT
Quality, Evolution, and Clinical Implications of Randomized, Controlled Trials on the Treatment of Lung Cancer: A Lost Opportunity for Meta-analysis
Nicolucci et al.
JAMA 1989;262:2101-2107.
ABSTRACT
What Can We Believe?
Brown
Arch Dermatol 1985;121:1391-1393.
ABSTRACT
|